0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects

References

• Burton MJ, Ramke J, Marques AP, et al. The lancet global health commission on global eye health: vision beyond 2020. Lancet Glob Health. 2021;9(4):e489–e551. doi:10.1016/S2214-109X(20)30488-5
   PubMed Web of Science ®Google Scholar
• GBD Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health. 2021;9(2):e144–e160. doi:10.1016/S2214-109X(20)30489-7
   PubMed Web of Science ®Google Scholar
• Donnenfeld ED, Solomon KD, Matossian C. Safety of IBI-10090 for inflammation associated with cataract surgery: phase 3 multicenter study. J Cataract Refract Surg. 2018;44(10):1236–1246. doi:10.1016/j.jcrs.2018.07.015
   PubMed Web of Science ®Google Scholar
• National Eye Institute. NEI charts a clearer future for cataract prevention and treatment; 2017. Available from: https://www.nei.nih.gov/about/news-and-events/news/nei-charts-clearer-future-cataract-prevention-and-treatment. Accessed January 11, 2023.
   Google Scholar
• American Academy of Ophthalmology Cataract and Anterior Segment Panel. Preferred practice pattern guidelines: cataract in the adult eye; 2021.
   Google Scholar
• Rossi T, Romano MR, Iannetta D, et al. Cataract surgery practice patterns worldwide: a survey. BMJ Open Ophthalmol. 2021;6(1):e000464. doi:10.1136/bmjophth-2020-000464
   PubMed Web of Science ®Google Scholar
• Donnenfeld E. Current use of non-steroidal anti-inflammatory drugs in the treatment of ocular inflammation related to cataract surgery. Eur Ophthal Rev. 2012;6(3):173–177.
   Google Scholar
• Hovanesian JA, Donnenfeld ED. Intracameral dexamethasone 9% vs prednisolone acetate 1% in controlling postoperative pain and inflammation in patients undergoing cataract surgery. J Cataract Refract Surg. 2022;48(8):906–911. doi:10.1097/j.jcrs.0000000000000887
   PubMed Web of Science ®Google Scholar
• Walters T, Bafna S, Vold S, et al. Efficacy and safety of sustained release dexamethasone for the treatment of ocular pain and inflammation after cataract surgery: results from two Phase 3 studies. J Clin Exp Ophthalmol. 2016;7(4):1.
   Google Scholar
• Shorstein NH, Myers WG. Drop-free approaches for cataract surgery. Curr Opin Ophthalmol. 2020;31(1):67–73. doi:10.1097/ICU.0000000000000625
   PubMed Web of Science ®Google Scholar
• Erichsen JH, Forman JL, Holm LM, Kessel L. Effect of anti-inflammatory regimen on early postoperative inflammation after cataract surgery. J Cataract Refract Surg. 2021;47(3):323–330. doi:10.1097/j.jcrs.0000000000000455
   PubMed Web of Science ®Google Scholar
• Flach AJ. Topical nonsteroidal antiinflammatory drugs in ophthalmology. Int Ophthalmol Clin. 2002;42(1):1–11.
   PubMedGoogle Scholar
• Flach AJ. Treatment of postoperative inflammation in ophthalmology. J Toxicol Cutaneous Ocul Toxicol. 2008;10(4):253–277. doi:10.3109/15569529109052135
   Google Scholar
• Schalnus R. Topical nonsteroidal anti-inflammatory therapy in ophthalmology. Ophthalmologica. 2003;217(2):89–98. doi:10.1159/000068563
   PubMed Web of Science ®Google Scholar
• Simone JN, Whitacre MM. Effects of anti-inflammatory drugs following cataract extraction. Curr Opin Ophthalmol. 2001;12(1):63–67.
   PubMed Web of Science ®Google Scholar
• Donnenfeld ED, Holland EJ, Solomon KD. Safety and efficacy of nepafenac punctal plug delivery system in controlling postoperative ocular pain and inflammation after cataract surgery. J Cataract Refract Surg. 2021;47(2):158–164. doi:10.1097/j.jcrs.0000000000000414
   PubMed Web of Science ®Google Scholar
• van Rensburg EJ, Meyer D. Astute and safe use of topical ocular corticosteroids in general practice: practical guidelines. Afr J Online. 2013;31(4):127–129.
   Google Scholar
• An JA, Kasner O, Samek DA, Levesque V. Evaluation of eyedrop administration by inexperienced patients after cataract surgery. J Cataract Refract Surg. 2014;40(11):1857–1861. doi:10.1016/j.jcrs.2014.02.037
   PubMed Web of Science ®Google Scholar
• Shah TJ, Conway MD, Peyman GA. Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy. Clin Ophthalmol. 2018;12:2223–2235. doi:10.2147/OPTH.S165722
   PubMed Web of Science ®Google Scholar
• Kim SJ, Schoenberger SD, Thorne JE, Ehlers JP, Yeh S, Bakri SJ. Topical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of Ophthalmology. Ophthalmology. 2015;122(11):2159–2168. doi:10.1016/j.ophtha.2015.05.014
   PubMed Web of Science ®Google Scholar
• Grob SR, Gonzalez-Gonzalez LA, Daly MK. Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions. Clin Ophthalmol. 2014;8:1281–1289. doi:10.2147/OPTH.S47569
   PubMedGoogle Scholar
• Rizzo S, Gambini G, De Vico U, Rizzo C, Kilian R. A one-week course of levofloxacin/dexamethasone eye drops: a review on a new approach in managing patients after cataract surgery. Ophthalmol Ther. 2022;11(1):101–111. doi:10.1007/s40123-021-00435-1
   PubMed Web of Science ®Google Scholar
• Kim T, Sall K, Holland EJ, Brazzell RK, Coultas S, Gupta PK. Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery. Clin Ophthalmol. 2019;13:69–86. doi:10.2147/OPTH.S185800
   PubMed Web of Science ®Google Scholar
• Fong R, Cavet ME, DeCory HH, Vittitow JL. Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies. Clin Ophthalmol. 2019;13:1427–1438. doi:10.2147/OPTH.S210597
   PubMed Web of Science ®Google Scholar
• Fong R, Silverstein BE, Peace JH, Williams JI, Vittitow JL. Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery. J Cataract Refract Surg. 2018;44(10):1220–1229. doi:10.1016/j.jcrs.2018.06.056
   PubMed Web of Science ®Google Scholar
• Korenfeld MS, Silverstein SM, Cooke DL, Vogel R, Crockett RS; Difluprednate Ophthalmic Emulsion 0.05% Study Group. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. J Cataract Refract Surg. 2009;35(1):26–34. doi:10.1016/j.jcrs.2008.09.024
   PubMed Web of Science ®Google Scholar
• Tyson SL, Bafna S, Gira JP, et al. Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery. J Cataract Refract Surg. 2019;45(2):204–212. doi:10.1016/j.jcrs.2018.09.023
   PubMed Web of Science ®Google Scholar
• Lotemax [package insert]. (Bausch & Lomb Incorporated); 2013.
   Google Scholar
• Durezol [package insert] (Alcon Laboratories, Inc.); 2016.
   Google Scholar
• Lotemax [package insert] (Bausch & Lomb, Inc.); 2016.
   Google Scholar
• Inveltys [package insert] (Kala Pharmaceuticals); 2018.
   Google Scholar
• Surface Ophthalmics. Surface ophthalmics announces positive top-line results from Phase II Trial for SURF-201 (Betamethasone 0.2% in Klarity® vehicle) for the treatment of post-cataract surgery pain and inflammation; 2021. Available from: https://www.prnewswire.com/news-releases/surface-ophthalmics-announces-positive-top-line-results-from-phase-ii-trial-for-surf-201-betamethasone-0-2-in-klarity-vehicle-for-the-treatment-of-post-cataract-surgery-pain-and-inflammation-301212617.html. Accessed January 13, 2023.
   Google Scholar
• Corbett MC, Hingorani M, Boultom JE, Shilling JS. Subconjunctival betamethasone is of benefit after cataract surgery. Eye. 1993;7:744–748.
   PubMed Web of Science ®Google Scholar
• Shah SM, McHugh JD, Spalton DJ. The effects of subconjunctival betamethasone on the blood aqueous barrier following cataract surgery: a double-blind randomised prospective study. Br J Ophthalmol. 1992;76(8):475–478. doi:10.1136/bjo.76.8.475
   PubMed Web of Science ®Google Scholar
• Lindstrom RL, Kaufman HE, Skelnik DL, et al. Optisol corneal storage medium. Am J Ophthalmol. 1992;114(3):345–356. doi:10.1016/s0002-9394(14)71803-3
   PubMed Web of Science ®Google Scholar
• Trattler WB, Majmudar PA, Donnenfeld ED, McDonald MB, Stonecipher KG, Goldberg DF. The Prospective Health Assessment of Cataract Patients’ Ocular Surface (PHACO) study: the effect of dry eye. Poster. Clin Ophthalmol. 2017;11:1423–1430. doi:10.2147/OPTH.S120159
   PubMed Web of Science ®Google Scholar
• Kasetsuwan N, Satitpitakul V, Changul T, Jariyakosol S. Incidence and pattern of dry eye after cataract surgery. PLoS One. 2013;8(11):e78657. doi:10.1371/journal.pone.0078657
   PubMed Web of Science ®Google Scholar
• Kwon JW, Chung YW, Choi JA, La TY, Jee DH, Cho YK. Comparison of postoperative corneal changes between dry eye and non-dry eye in a murine cataract surgery model. Int J Ophthalmol. 2016;9(2):218–224. doi:10.18240/ijo.2016.02.06
   PubMed Web of Science ®Google Scholar
• Yu Y, Hua H, Wu M, et al. Evaluation of dry eye after femtosecond laser-assisted cataract surgery. J Cataract Refract Surg. 2015;41(12):2614–2623. doi:10.1016/j.jcrs.2015.06.036
   PubMed Web of Science ®Google Scholar
• Porela-Tiihonen S, Kaarniranta K, Kokki M, Purhonen S, Kokki H. A prospective study on postoperative pain after cataract surgery. Clin Ophthalmol. 2013;7:1429–1435. doi:10.2147/OPTH.S47576
   PubMedGoogle Scholar
• Celestone Soluspan [package insert] (Merck Sharp & Dohme Corp.); 2018.
   Google Scholar
• Betnesol eye, ear and nose drops solution 0.1% [package insert]. (RPH Pharmaceuticals); 2017.
   Google Scholar
• Arthur KE, Wolff JC, Carrier DJ. Analysis of betamethasone, dexamethasone and related compounds by liquid chromatography/electrospray mass spectrometry. Rapid Commun Mass Spectrom. 2004;18(6):678–684. doi:10.1002/rcm.1386
   PubMed Web of Science ®Google Scholar
• Fung AT, Tran T, Lim LL, et al. Local delivery of corticosteroids in clinical ophthalmology: a review. Clin Exp Ophthalmol. 2020;48(3):366–401. doi:10.1111/ceo.13702
   PubMed Web of Science ®Google Scholar
• National Health Service. Corticosteroids; 2023. Available from: https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/11.-eye/11-1-2-inflammatory-eye-conditions/11-4-1-corticosteroids. Accessed March 24, 2023.
   Google Scholar
• Corticosteroids and the Eye; 2023. Available from: https://www.formularywkccgmtw.co.uk/therapeutic-sections/eye/inflammatory-eye-conditions/corticosteroids-and-the-eye/. Accessed March 27, 2023.
   Google Scholar
• Maxidex [package insert] (Alcon Laboratories, Inc.); 2017.
   Google Scholar
• Dreyer SJ, Beckworth WJ. Commonly used medications in procedures. In: Lennard TA, Walkowski S, Singla AK, Vivian DG, editors. Pain Procedures in Clinical Practice. 3rd ed. Hanley & Belfus; 2011:2.
   Google Scholar
• Aragona P, Postorino EI, Aragona E. Post-surgical management of cataract: light and dark in the 2020s. Eur J Ophthalmol. 2021;31(2):287–290. doi:10.1177/1120672120963458
   PubMed Web of Science ®Google Scholar
• Schechter BA. Use of topical bromfenac for treating ocular pain and inflammation beyond cataract surgery: a review of published studies. Clin Ophthalmol. 2019;13:1439–1460. doi:10.2147/OPTH.S208700
   PubMed Web of Science ®Google Scholar
• Cho H, Wolf KJ, Wolf EJ. Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution. Clin Ophthalmol. 2009;3:199–210.
   PubMedGoogle Scholar
• Donnenfeld E, Holland E. Dexamethasone intracameral drug-delivery suspension for inflammation associated with cataract surgery: a randomized, placebo-controlled, Phase III trial. Ophthalmology. 2018;125(6):799–806. doi:10.1016/j.ophtha.2017.12.029
   PubMed Web of Science ®Google Scholar
• Foster B. Same-day versus next-day dexamethasone intracanalicular insert administration for inflammation and pain control following cataract surgery: a retrospective analysis. Clin Ophthalmol. 2021;15:4091–4096. doi:10.2147/OPTH.S335764
   PubMed Web of Science ®Google Scholar
• Fram N, Alsetri H, Shiler O, Paterno PJ, Cabang J. Retrospective study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation after cataract and corneal surgery. Clin Ophthalmol. 2022;16:4065–4074. doi:10.2147/OPTH.S386702
   PubMed Web of Science ®Google Scholar
• Saenz B, Ferguson TJ, Abraham N, Mueller BH, Parkhurst GD. Evaluation of same-day versus next-day implantation of intracanalicular dexamethasone for the control of postoperative inflammation and pain following cataract surgery. Clin Ophthalmol. 2021;15:4615–4620. doi:10.2147/OPTH.S334297
   PubMed Web of Science ®Google Scholar
• Kim SJ, Patel SN, Sternberg P Jr. Routine use of nonsteroidal anti-inflammatory drugs with corticosteroids in cataract surgery: beneficial or redundant? Ophthalmology. 2016;123(3):444–446. doi:10.1016/j.ophtha.2015.10.042
   PubMed Web of Science ®Google Scholar
• Lindholm JM, Taipale C, Ylinen P, Tuuminen R. Perioperative subconjunctival triamcinolone acetonide injection for prevention of inflammation and macular oedema after cataract surgery. Acta Ophthalmol. 2020;98(1):36–42. doi:10.1111/aos.14175
   PubMed Web of Science ®Google Scholar
• Dieleman M, Wubbels RJ, van Kooten-Noordzij M, de Waard PW. Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery. J Cataract Refract Surg. 2011;37(9):1589–1597. doi:10.1016/j.jcrs.2011.03.049
   PubMed Web of Science ®Google Scholar
• Bacharach J, McCabe C, Jackson M, et al. First real-world, multicenter, post-marketing, retrospective study of dexamethasone intraocular suspension for inflammation after cataract surgery. Clin Ophthalmol. 2022;16:1783–1794. doi:10.2147/OPTH.S357267
   PubMed Web of Science ®Google Scholar
• Lee A, Blair HA. Dexamethasone intracanalicular insert: a review in treating post-surgical ocular pain and inflammation. Drugs. 2020;80(11):1101–1108. doi:10.1007/s40265-020-01344-6
   PubMed Web of Science ®Google Scholar
• Mencucci R, Ach T, Liekfeld A, et al. Reduced posology of an ophthalmic hydrogel containing dexamethasone/netilmicin to prevent and treat ocular inflammation after cataract surgery: efficacy and tolerability. Adv Ther. 2022;39(12):5474–5486. doi:10.1007/s12325-022-02295-y
   PubMed Web of Science ®Google Scholar
• Garg P, Tuteja N, Qayum S. To study the efficacy of difluprednate ophthalmic emulsion and prednisolone acetate ophthalmic suspension on post-operative inflammation in cataract surgery. J Clin Diagn Res. 2016;10(12):NC05–NC08. doi:10.7860/JCDR/2016/21690.9035
   PubMedGoogle Scholar
• Schwartz GF, Hollander DA, Williams JM. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension. Curr Med Res Opin. 2013;29(11):1515–1522. doi:10.1185/03007995.2013.833898
   PubMed Web of Science ®Google Scholar